![Bruce Beutel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce Beutel
No open positions remaining
Profile
Bruce A. Beutel is the founder of Passkey Therapeutics, Inc. Dr. Beutel is currently a Director at GRO Biosciences, Inc. since 2021 and a Director at Boston Immune Technologies & Therapeutics, Inc. Formerly, Dr. Beutel was Senior Director-Target & Lead Discovery at Abbott Laboratories from 1995 to 2007, Executive Director at Merck & Co., Inc., Group Head-Discovery & Senior Scientist at PharmaGenics, Inc. from 1993 to 1995, Chief Scientific Officer at Znomics, Inc. from 2008 to 2009, and Venture Partner at Qiming US Ventures Management, LLC from 2021 to 2022.
Dr. Beutel completed undergraduate studies at The University of Chicago and earned a doctorate from the University of Wisconsin.
Bruce Beutel active positions
| Companies | Position | Start |
|---|---|---|
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops protein-based therapies | Director/Board Member | 2021-12-08 |
Boston Immune Technologies & Therapeutics, Inc.
 Boston Immune Technologies & Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapy | Director/Board Member | - |
Enveda Therapeutics, Inc.
 Enveda Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery platform | Director/Board Member | 2021-12-31 |
Former positions of Bruce Beutel
| Companies | Position | End |
|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Private Equity Analyst | 2022-11-30 |
Znomics, Inc.
 Znomics, Inc. Financial ConglomeratesFinance Operates as a shell company | Chief Tech/Sci/R&D Officer | 2009-06-02 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 2006-12-31 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Chief Tech/Sci/R&D Officer | 1994-12-31 |
| MERCK & CO., INC. | Director/Board Member | - |
Training of Bruce Beutel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products for cancer | Commercial Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Znomics, Inc.
Znomics, Inc. Financial ConglomeratesFinance Operates as a shell company | Finance |
GRO Biosciences, Inc.
GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops protein-based therapies | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
Boston Immune Technologies & Therapeutics, Inc.
Boston Immune Technologies & Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapy | Health Technology |
Enveda Therapeutics, Inc.
Enveda Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a AI-enabled drug discovery platform | Technology Services |
- Stock Market
- Insiders
- Bruce Beutel
